Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Naumov, J. Perelman, V. Kolosov, D. Ivanoshchuk, V. Maksimov, M. Voevoda, S. Naryshkina (Blagoveshchensk, Novosibirsk, Russian Federation). Effect of ADRB2 gene polymorphism on treatment outcomes in asthmatics: Cold airway hyperresponsiveness and asthma control. Eur Respir J 2014; 44: Suppl. 58, 4778

Member's Comments

No comment yet.

Related content which might interest you: Effect of TRPV4 gene polymorphisms on osmotic airway hyperresponsiveness in patients with asthma Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 TRPM8 gene polymorphisms and their relation to cold airway hyperresponsiveness in patients with bronchial asthma Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Achievement of asthma control in patients with cold airway hyperresponsiveness at different variants of basic therapy Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Influence of beta2-adrenergic receptor polymorphism on methacholine hyperresponsiveness in asthmatic patients Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Role of TRPV1 and TRPV2 gene polymorphisms in the development of airway hyperresponsiveness to osmotic stimuli in patients with asthma Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Association of FCER2 polymorphism with IgE levels and exacerbations in asthmatic children Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Relation of IL-33 and PSMA6 gene polymorphisms in asthma patients Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Study of the correlations between FENO and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Re-sequencing of IL33 and IL1RL1 in severe asthma patients identifies novel variation Source: International Congress 2014 – Genes and environment in asthma and COPD Year: 2014 Small airway indices, bronchodilator response and asthma control in children Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Formoterol-induced downregulation of the beta2-adrenoceptor in asthmatics with homozygous glycine-16 polymorphism Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Polymorphisms in all three ORMDL genes are associated with asthma and their mRNA expression is increased in asthmatics Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology Year: 2014 Association of thymic stromal lymphopoietin gene polymorphisms with atopic status, pulmonary function and airway hyperresponsiveness in a Japanese adult asthmatic population Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 Blockade of TSLP pathway alters asthma biomarkers Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Bronchial hyperresponsiveness to methacholine in relation to asthma control – Results from the MIDAS study Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Impact of the genetic variation of GLCCI1 on clinical features of asthmatic patinets Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016